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http://dx.doi.org/10.1016/j.kjms.201Abstract Mesothelioma often originates in the pleura and less frequently in the peritoneum.
This article describes a rare case of diffuse malignant peritoneal mesothelioma in a 54-year-old
male construction worker who was admitted to our hospital with a 2-month history of progres-
sive abdominal distention. Abdominal computed tomography revealed extensive peritoneal no-
dularity and omental cake along with massive ascites. Imaging findings initially suggested
peritoneal carcinomatosis, primary peritoneal carcinoma, and tuberculous peritonitis. Laparo-
scopic biopsy of the omentum and peritoneum confirmed the diagnosis of malignant peritoneal
mesothelioma of epitheloid type. Although systemic chemotherapy was administered, no tu-
mor regression was found. The patient finally died of nosocomial infection.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Malignant mesothelioma is a highly aggressive primary
neoplasm of the serosal lining of the pleura, peritoneum,
pericardium, or tunica vaginalis [1]. Primary diffuse ma-
lignant peritoneal mesothelioma (DMPM) is a rare clinical
entity. Only 33% of those diagnosed with DMPM have a
history of asbestos exposure [2]. This article describes a 54-
year-old male patient who was admitted to our hospitalf Gastroenterology, Depart-
Veterans General Hospital,
62, Taiwan.
o.com.tw (P.-I. Hsu).
hsiung Medical University. Publish
3.05.003with progressive abdominal distention and was diagnosed
with DMPM. The clinical and histopathological features of
this rare lesion are described based on a review of previous
literature.Case report
A 54-year-old male construction worker was admitted to
our hospital with a 2-month history of progressive abdom-
inal distention. Despite anorexia, the patient did not
experience nausea, vomiting, abdominal pain, or body
weight loss. He also had a 25-year history of heavy alcohol
consumption. Physical examination revealed hypoactiveed by Elsevier Taiwan LLC. All rights reserved.
Figure 2. Computed tomography scan of the abdomen shows
omental cake (arrows).
Malignant peritoneal mesothelioma 643bowel sound and abdominal shifting dullness. Paracentesis
indicated exudative features with lymphocytic predomi-
nance (95%) and serum-ascites-albumin gradient less than
1.1 g/dL. The levels of protein, glucose, lactate dehydro-
genase, and amylase were 3.3 g/dL, 39 mg/dL, 462 U/L,
and 30 U/L, respectively. No malignant cells were found in
ascites. Additionally, ascitic fluid culture and culture for
acid-fast bacilli were negative. Chest X-ray revealed no
active lung lesions such as pleural thickening and pleural
effusion. A computed tomography (CT) scan of abdomen
disclosed extensive peritoneal nodularity (Fig. 1, arrow)
and omental cake (Fig. 2, arrows) along with massive as-
cites. No elevation of serum CA19-9, carcinoembryonic
antigen, or alpha fetoprotein level was noted. Laparoscopic
biopsy of peritoneum revealed turbid ascites and peritoneal
nodularity (Fig. 3, arrow). Microscopically, the specimen
comprised epitheloid mesothelioma, consisting of solid
nests of neoplastic epitheloid cells with slightly hyper-
chromatic nuclei and small nucleoli. Tumor cells invaded
the adjacent connective tissue (Fig. 4). Malignant perito-
neal mesothelioma, epitheloid type, was diagnosed by
immunohistochemistry, which exhibited positive staining
for Wilms’ tumor 1 antigen (WT1), D2-40, calretinin, cyto-
keratin, and AE1/AE3, and negative staining for muci-
carmine, carcinoembryonic antigen, and MOC-31. Although
systemic chemotherapy was administered, no tumor
regression was observed. The patient eventually died of
nosocomial infection.
Discussion
As a highly aggressive neoplasm of serosal surfaces, malig-
nant mesothelioma may involve the pleura, less frequently
the peritoneum, and, in a small percentage of cases, the
tunica vaginalis, testis, or pericardium [1]. DMPM is a rareFigure 1. Computed tomography scan of the abdomen shows
massive ascites and peritoneal nodularity (arrow).clinical entity, accounting for approximately 30% of all
mesothelioma [3]. Only 33% of DMPM patients have a history
of asbestos exposure [2]. According to a previous study,
asbestos exposure is the etiology in 60% of DMPM in men and
23% in women [4]. DMPM has also been associated with
radiation therapy, recurrent peritonitis, mica exposure,
and administration of thorium dioxide [5]. Although the
patient in this study had no definite history of asbestos
exposure, as a construction worker, he had a higher likeli-
hood of coming into contact with fire-retardant coatings,
cement, bricks, pipes, flooring, and roofing than the gen-
eral population.
The overall incidence of this disease is higher in males
than in females, which may be due to a higher incidence of
asbestos-related occupations in men [5]. Clinically, symp-
toms in these patients include the following: ascites (77%),Figure 3. Diagnostic laparoscopy reveals turbid ascites and
peritoneal nodularity (arrow).
Figure 4. Microscopic section shows the tumor is composed
of epitheloid mesothelioma, consisting of solid nests of
neoplastic epitheloid cells with slightly hyperchromatic nuclei
and small nucleoli. Tumor cells invade the adjacent connective
tissue (hematoxylin and eosin, 400).
644 C.-A. Shih et al.abdominal pain (69%), asthenia (43%), weight loss (32%),
anorexia (30%), abdominal mass (30%), fever (22%), diar-
rhea (17%), vomiting (15%), and inguinal or umbilical hernia
(5e10%) in various associations [6]. This article describes a
54-year-old man inflicted with ascites. In Taiwan, the
common causes of ascites include liver cirrhosis, secondary
peritoneal carcinomatosis, and tuberculous peritonitis. As-
cites due to DMPM is extremely rare.
Radiological assessment is typically undertaken using CT
scan, although magnetic resonance imaging and positron
emission tomography have been prescribed more recently
[6]. DMPM may have multiple manifestations on CT,
including thickening of the pleura, peritoneum, and mes-
entery; nodules of various sizes and shapes; mesenteric or
omental infiltrations; omental caking; ascites; bone
destruction; and lymphadenopathy [7]. According to imag-
ing findings, the differential diagnosis for a typical DMPM
includes peritoneal carcinomatosis, primary peritoneal
carcinoma, ovarian carcinoma in women, lymphomatosis,
and tuberculous peritonitis.
Diagnosis can be made by ascitic fluid cytology, CT scan,
and laparoscopy. Cytological examination of ascitic fluid
removed by paracentesis rarely results in a positive finding
[8]. According to the data review of previous case reports
and the current case of DMPM [9e12], the sensitivity of
ascitic fluid cytology in the diagnosis of malignant meso-
thelioma was 54% (7/13). In clinical practice, ascitic fluid
cytology can be used as an initial diagnostic modality for
malignant mesothelioma. However, the definite diagnosis
of DMPM often depends on laparoscopy or open surgery with
biopsy. The gross appearance of mesothelioma is charac-
terized by soft, grayish-white, papillary nodules or masses
extending over peritoneal surfaces. In pathology, malignant
mesothelioma is characterized by staining for calretinin,
cytokeratin 5/6, epithelial membrane antigen (EMA), WT1,
antimesothelial cell antibody-1, and mesothelin without
the absence of staining the markers for malignancies of the
gastrointestinal tract including carcinoembryonic antigenand MOC-31 [2,13]. DMPM is categorized into three patho-
logic subtypes: epithelial (56%), sarcomatous (32%), and
mixed (13%) [3]. In this study, cytological examination of
ascitic fluid failed to identify cancer cells. DMPM was
diagnosed based on laparoscopic biopsy.
Previously, DMPM was treated with a combination of
systemic chemotherapy, palliative surgery, and, in a few
patients, total abdominal radiation capable of achieving a
median survival of 12 months [14]. Prognosis of DMPM is
poor, with a median survival rate of <1 year [6,15]. How-
ever, new therapeutic strategies (e.g., combined approach
with cytoreduction surgery and hyperthermic intraperito-
neal chemotherapy) have prolonged survival considerably
in selected cases in recent years [6,14].
DMPM is a rare disease characterized by a difficult
diagnosis, different presentations, variable course, and
poor prognosis. DMPM is a rare cause of ascites in Taiwan.
However, it should be considered in patients inflicted with
ascites, particularly in those without cirrhosis, pulmonary
tuberculosis, and nonperitoneal malignancy.References
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